US oncologists and hematologists receive more payments from the pharmaceutical and medical device industries than the average US physician. US oncologists and hematologists receive more payments from the pharmaceutical and medical device industries than the average US physician.
Explainability, consent, and responsibility are noted as challenges that may hinder implementation of artificial intelligence (AI) in cancer care, according to a new study.